Anpario plc (AIM:ANP)

Market Cap	104.01M +31.3%
Revenue (ttm)	47.18M +23.5%
Net Income	6.75M +64.2%
EPS	0.38 +55.4%
Shares Out	20.60M
PE Ratio	13.31
Forward PE	12.04
Dividend	0.13 (2.48%)
Ex-Dividend Date	Jul 9, 2026

Volume	10,115
Average Volume	64,085
Open	509.90
Previous Close	505.00
Day's Range	501.26 - 519.00
52-Week Range	370.00 - 580.00
Beta	0.99
RSI	61.40
Earnings Date	Mar 31, 2026

About Anpario

Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzy...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1996
• Employees: 162
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ANP

Financial Performance

In 2025, Anpario's revenue was 47.18 million, an increase of 23.51% compared to the previous year's 38.20 million. Earnings were 6.75 million, an increase of 64.20%.